Company Filing History:
Years Active: 2020-2021
Title: Innovations of Jorge Esquivias Provencio
Introduction
Jorge Esquivias Provencio is a notable inventor based in Tres Cantos, Spain. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of tuberculosis. With a total of 2 patents, his work focuses on developing innovative compounds that can aid in combating mycobacterial infections.
Latest Patents
His latest patents include "Tetrazole compounds and their use in the treatment of tuberculosis." This invention relates to a compound of Formula (I) or a pharmaceutically acceptable salt thereof, which is utilized in therapy for treating diseases caused by mycobacteria, such as tuberculosis. Another significant patent is the "Antituberculosis agent," which pertains to the use of 6-((4-(2,3-dimethylphenoxy)piperidin-1-yl)methyl)pyrimidine-2,4(1H,3H)-dione or its pharmaceutically acceptable salts in therapeutic applications. This patent also covers pharmaceutical formulations that include this compound.
Career Highlights
Jorge Esquivias Provencio is associated with GlaxoSmithKline Intellectual Property Development Limited, where he continues to innovate in the pharmaceutical sector. His work is crucial in the ongoing fight against tuberculosis, a disease that affects millions worldwide.
Collaborations
He collaborates with David Barros Aguirre, contributing to the advancement of their research and development efforts in the pharmaceutical industry.
Conclusion
Jorge Esquivias Provencio's contributions to the field of pharmaceuticals, particularly in tuberculosis treatment, highlight his role as an influential inventor. His innovative patents and collaborations reflect his commitment to improving healthcare solutions.